Antisense oligonucleotides: A systematic high-throughput approach to target validation and gene function determination

Drug Discovery Today

Volumn 4, Issue 12, 1999, Pages 562-567

  Taylor, Margaret F ^a   Wiederholt, Kristin ^a   Sverdrup, Fran ^a  

^a Sequitur Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; ANTISENSE OLIGONUCLEOTIDE; BETA ACTIN; CGP 69846A; FOMIVIRSEN; G 1128; GENE EXPRESSION MODULATOR 132; INX 3001; ISIS 2503; ISIS 3521; MESSENGER RNA; OBLIMERSEN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; TRECOVIRSEN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; DRUG DEVELOPMENT; DRUG SYNTHESIS; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; RETINITIS; REVIEW; RHEUMATOID ARTHRITIS; TECHNOLOGY;

EID: 0033485278     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(99)01392-6     Document Type: Review

References (37)

1. Woolf T.M.et al. Nucleic Acids Res. 18:1990;1763-1769.
2. Woolf T.M., Melton D.A., Jennings C.G.B. Proc. Natl. Acad. Sci. U. S. A. 89:1992;7305-7309.
3. Burgess T. Proc. Natl. Acad. Sci. U. S. A. 92:1992;4051-4055.
4. Krieg A.M. Nature. 374:1995;546-549.
5. Stein C.A. Nat. Med. 1:1995;1119-1121.
6. Flanagan W.M. Cancer Metastasis Rev. 17:1998;169-176.
7. Crooke S.T. Antisense Nucleic Acid Drug Dev. 8:1998;115-122.
8. Marwick C. J. Am. Med. Assoc. 280:1998;871.
9. Stix G. Sci. Am. 297:1998;46-50.
10. Bennett C.F. Biochem. Pharmacol. 55:1998;9-19.
11. Giles R.V.et al. Nucleic Acids Res. 26:1998;1567-1575.
12. Agrawal S., Zhao Q. Antisense Nucleic Acid Drug Dev. 8:1998;135-139.
13. McKay R.A.et al. Nucleic Acids Res. 24:1996;411-417.
14. McKay R.A.et al. J. Biol. Chem. 274:1999;1715-1722.
15. Tereshko V.et al. Biochemistry. 37:1998;10626-10634.
16. Monia B.P.et al. J. Biol. Chem. 268:1993;14514-14522.
17. Monia B.P.et al. J. Biol. Chem. 271:1996;14533-14540.
18. Crooke S.T. Antisense Nucleic Acid Drug Dev. 8:1998;133-134.
19. Baker B.F.et al. J. Biol. Chem. 272:1997;11994-12000.
20. Liebhaber S.A., Cash F., Eshleman S.S. J. Mol. Biol. 226:1992;2-13.
21. Flanagan W., Su L., Wagner R. Nat. Biotechnol. 14:1996;1139-1145.
22. Flanagan W.M., Wagner R.W. Mol. Cell. Biochem. 172:1997;213-225.
23. Flanagan W.M.et al. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3513-3518.
24. Balow G.et al. Nucleic Acids Res. 26:1998;3350-3357.
25. Xu X.S.et al. J. Biol. Chem. 273:1998;33230-33238.
26. Rastan S., Beeley L.J. Curr. Opin. Genet. Dev. 7:1997;777-783.
27. Borrebaeck C.A.K. Immunol. Today. 19:1998;524-527.
28. Wagner R.W.et al. Nat. Biotechnol. 14:1996;840-844.
29. Marcusson E.G.et al. Nucleic Acids Res. 26:1998;2016-2023.
30. Fisher T.et al. Nucleic Acids Res. 21:1993;3857-3865.
31. Taylor G.R., Robinson P. Curr. Opin. Biotechnol. 9:1998;35-42.
32. Zhao S.C.et al. Bone. 23:1998;S241.
33. Schena M.et al. Trends Biotechnol. 16:1998;301-307.
34. Oliver S.G.et al. Trends Biotechnol. 16:1998;373-378.
35. Marton M.J.et al. Nat. Med. 4:1998;1293-1301.
36. Collins F.S.et al. Science. 282:1998;682-689.
37. Branch A.D. Trends Biol. Sci. 23:1998;45-50.